Natco Pharma

Natco Pharma is currently trading at Rs. 1105.00, up by 114.20 points or 11.53% from its previous closing of Rs. 990.80 on the BSE. The scrip opened at Rs. 1188.95 and has touched a high and low of Rs. 1188.95 and Rs. 1100.00 respectively. So far 109062 shares were traded on the counter. The BSE … Read more

Natco Pharma has received Emergency Use approval for Baricitinib tablets, 1mg, 2mg and 4mg strengths from Central Drugs Standard Control Organization (CDSCO) in India. Baricitinib in combination with Remdesivir, is used for treatment of COVID-19 positive patients. Natco will be requesting a Compulsory License based on emergency use and in light of the grave and … Read more